
    
      This Post Approval Study is a multi-center, prospective, single arm cohort study to evaluate
      the long-term safety, long-term effectiveness, and survival rate in subjects implanted with
      the remed System from the remed System Pivotal Trial. Only subjects who were implanted and
      actively being followed as part of the remed System Pivotal Trial are eligible. An
      individual subject's participation is expected to continue to five years post remed System
      implant.
    
  